CV Information
PROFESOR MADYA DR. SHARIFAH EMILIA BINTI TUAN SHARIF
| |
---|---|
Grant's Name,"Project's Title" (Research Period)(Role)[Sponsorship]
| |
1 | RESEARCH UNIVERSITY (TOP DOWN), "THE CHARACTERIZATION MDM2 AND CDK4 GENES AMPLIFICATIONS AND ITS SURVIVAL AMONG LIPOSARCOMA PATIENTS" (01.03.2021 - 29.02.2024) (Team Member) [ USM (RU TOP-DOWN) ] - Source: eR&I |
2 | BRIDGING GRANT, "EVALUATION OF CLINICOPATHOLOGICAL DATA IN OSTEOSARCOMA PATIENTS WITH POSITIVE EXPRESSION OF RANKL IMMUNOHISTOCHEMISTRY" (15.12.2018 - 14.12.2019) (Principal) [ UNIVERSITI SAINS MALAYSIA (USM) ] - Source: eR&I |
3 | SHORT TERM - ACADEMIC STAFF, "THE VALIDITY OF TLE-1 AS AN IMMUNOHISTOCHEMICAL MARKER FOR SYNOVIAL SARCOMA AND ITS ASSOCIATION WITH TRANSLOCATION T(X; 18)" (15.03.2014 - 14.03.2016) (Principal) [ USM (JANGKA PENDEK) ] - Source: eR&I |
4 | SHORT TERM - ACADEMIC STAFF, "EXPRESSION OF AMACR (P504S) AND P63 IN DIFFERENTIATING BENIGN MALIGNANT FOCI IN PROSTATIC NEEDLE BIOPSY SPECIMEN" (15.03.2011 - 14.03.2013) (Principal) [ USM (JANGKA PENDEK) ] - Source: eR&I |
5 | , "PROSTATE CANCER AND ITS MIMICKERS IN ROUTINE PROSTATIC TISSUE BIOPSY IN HOSPITAL UNIVERSITI SAINS MALAYSIA (HUSM); A DIAGNOSIS WHICH COULD BE MISSED" (03.11.2009 - 02.11.2010) (Principal) [ USM (INSENTIF) ] - Source: eR&I |
6 | , "THE CHARACTERIZATION OF MDM2 AND CDK4 GENE AMPLIFICATIONS AND ITS SURVIVAL AMONG LIPOSARCOMA PATIENTS" (01.03.2021 - 29.02.2024) [ RUT TOP DOWN ] - Source: HCMSv3 |
7 | , "SHARIFAH EMILIA BINTI TUAN SHARIF, -, THE UTILITY OF H3K27 TRI-METHYLATION IMMUNOHISTOCHEMISTRY IN DIFFERENTIATING MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) AND ITS HISTOLOGIC MIMICKERS, RM3,000.00," (27.04.2017 - 26.04.2018) [ USAINS ] - Source: HCMSv3 |
8 | , "THE DETERMINATION OF AGREEMENT USING TLE-1 IMMUNOHISTOCHEMISTRY MARKER AND FLUORESCENCE IN SITU HYBRIDIZATION (FISH) IN SYNOVIAL SARCOMA CASES" (10.08.2016 - 10.08.2018) [ USAINS ] - Source: HCMSv3 |